French biotech firm Acticor Biotech snags Series B funding
French biotech firm Acticor Biotech has secured 15.3 million euros in Series B funding. Newton BioCapital led the round with participation from other investors that included Mirae Capital, CMS Medical Venture Investment Limited, A&B (HK) and CapDecisif Management.
17 October 2018•1 min read
